Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Rare Predicted Loss-Of-Function Variants of Type I Ifn Immunity Genes Are Associated With Life-Threatening Covid-19 Publisher



Matuozzo D1, 2 ; Talouarn E1, 2 ; Marchal A1, 2 ; Zhang P3 ; Manry J1, 2 ; Seeleuthner Y1, 2 ; Zhang Y4 ; Bolze A5 ; Chaldebas M3 ; Milisavljevic B3 ; Gervais A1, 2 ; Bastard P1, 2, 3, 6 ; Asano T3 ; Bizien L1, 2 Show All Authors
Authors
  1. Matuozzo D1, 2
  2. Talouarn E1, 2
  3. Marchal A1, 2
  4. Zhang P3
  5. Manry J1, 2
  6. Seeleuthner Y1, 2
  7. Zhang Y4
  8. Bolze A5
  9. Chaldebas M3
  10. Milisavljevic B3
  11. Gervais A1, 2
  12. Bastard P1, 2, 3, 6
  13. Asano T3
  14. Bizien L1, 2
  15. Barzaghi F7
  16. Abolhassani H8, 9
  17. Abou Tayoun A10, 11
  18. Aiuti A12, 13
  19. Alavi Darazam I14, 15
  20. Allende LM16
  21. Alonsoarias R17
  22. Arias AA3, 19, 20
  23. Aytekin G21
  24. Bergman P22, 23
  25. Bondesan S24
  26. Bryceson YT25
  27. Bustos IG26
  28. Cabreramarante O27
  29. Carcel S28
  30. Carrera P24
  31. Casari G29, 30
  32. Chaibi K31, 32
  33. Colobran R33, 34, 35
  34. Condinoneto A36
  35. Covill LE25
  36. Delmonte OM4
  37. El Zein L37
  38. Flores C38, 39, 40, 41
  39. Gregersen PK42
  40. Gut M43
  41. Haerynck F44
  42. Halwani R45
  43. Hancerli S46
  44. Hammarstrom L8
  45. Hatipoglu N47
  46. Karbuz A48
  47. Keles S49
  48. Kyheng C50
  49. Leonlopez R28
  50. Franco JL51
  51. Mansouri D52, 53, 54
  52. Martinezpicado J55, 57, 58, 59
  53. Metin Akcan O49
  54. Migeotte I60
  55. Morange PE61, 62
  56. Morelle G50
  57. Martinnalda A33, 63, 64
  58. Novelli G65, 66
  59. Novelli A67
  60. Palabiyik F47
  61. Panhammarstrom Q8
  62. De Diego RP69
  63. Planasserra L70, 71
  64. Pleguezuelo DE16
  65. Prando C72
  66. Pujol A58, 70, 71
  67. Reyes LF26
  68. Riviere JG33, 63, 64
  69. Rodriguezgallego C73, 74
  70. Rojas J51
  71. Roverequerini P13, 75
  72. Schluter A70, 71
  73. Shahrooei M76, 77
  74. Sobh A78
  75. Solerpalacin P33, 63, 64
  76. Tandjaouilambiotte Y79
  77. Tipu I80
  78. Tresoldi C81
  79. Troya J82
  80. Van De Beek D83
  81. Zatz M84
  82. Zawadzki P85, 86
  83. Almuhsen SZ87
  84. Alosaimi MF87
  85. Alsohime FM87
  86. Barisfeldman H88, 89
  87. Butte MJ90
  88. Constantinescu SN91, 92, 93, 94
  89. Cooper MA95
  90. Dalgard CL96, 97
  91. Fellay J98, 99, 100
  92. Heath JR101
  93. Lau YL102
  94. Lifton RP103, 104, 105
  95. Maniatis T106, 107
  96. Mogensen TH108, 109
  97. Von Bernuth H110
  98. Lermine A111
  99. Vidaud M111
  100. Boland A112
  101. Deleuze JF112
  102. Nussbaum R113
  103. Kahnkirby A113
  104. Mentre F114
  105. Tubiana S115
  106. Gorochov G116
  107. Tubach F117
  108. Hausfater P118, 119
  109. Casanova JL1, 2, 3, 122
  110. Ozcelik T68
  111. Meyts I120
  112. Zhang SY1, 2, 3
  113. Puel A1, 2, 3
  114. Notarangelo LD121
  115. Boissondupuis S1, 2, 3
  116. Su HC4
  117. Boisson B1, 2, 3
  118. Jouanguy E1, 2, 3
  119. Zhang Q1, 2, 3
  120. Abel L1, 2, 3
  121. Cobat A1, 2, 3

Source: Genome Medicine Published:2023


Abstract

Background: We previously reported that impaired type I IFN activity, due to inborn errors of TLR3- and TLR7-dependent type I interferon (IFN) immunity or to autoantibodies against type I IFN, account for 15–20% of cases of life-threatening COVID-19 in unvaccinated patients. Therefore, the determinants of life-threatening COVID-19 remain to be identified in ~ 80% of cases. Methods: We report here a genome-wide rare variant burden association analysis in 3269 unvaccinated patients with life-threatening COVID-19, and 1373 unvaccinated SARS-CoV-2-infected individuals without pneumonia. Among the 928 patients tested for autoantibodies against type I IFN, a quarter (234) were positive and were excluded. Results: No gene reached genome-wide significance. Under a recessive model, the most significant gene with at-risk variants was TLR7, with an OR of 27.68 (95%CI 1.5–528.7, P = 1.1 × 10−4) for biochemically loss-of-function (bLOF) variants. We replicated the enrichment in rare predicted LOF (pLOF) variants at 13 influenza susceptibility loci involved in TLR3-dependent type I IFN immunity (OR = 3.70[95%CI 1.3–8.2], P = 2.1 × 10−4). This enrichment was further strengthened by (1) adding the recently reported TYK2 and TLR7 COVID-19 loci, particularly under a recessive model (OR = 19.65[95%CI 2.1–2635.4], P = 3.4 × 10−3), and (2) considering as pLOF branchpoint variants with potentially strong impacts on splicing among the 15 loci (OR = 4.40[9%CI 2.3–8.4], P = 7.7 × 10−8). Finally, the patients with pLOF/bLOF variants at these 15 loci were significantly younger (mean age [SD] = 43.3 [20.3] years) than the other patients (56.0 [17.3] years; P = 1.68 × 10−5). Conclusions: Rare variants of TLR3- and TLR7-dependent type I IFN immunity genes can underlie life-threatening COVID-19, particularly with recessive inheritance, in patients under 60 years old. © 2023, The Author(s).
Other Related Docs